Objective: To assess the mediating and moderating roles of maternal education on ethnic disparities in children's vaccination status in Peru.
Methods: This was a cross-sectional study based on the secondary analysis of the 2023 Demographic and Health Survey. Children's vaccination status was defined as having completely received BCG; three doses of DPT and polio vaccines; and MMR vaccine by 12 months of age. Linear and Poisson regression models by ethnicity were fitted to assess the effect of maternal education on vaccination status. The 4-way decomposition using interventional analogues of natural effects was performed with the g-formula to assess the mediating and moderating roles of education on the disparity in vaccination status by mother's self-reported ethnicity (Indigenous versus Mestizos).
Results: A total of 5,622 Indigenous and 6,939 Mestizo children were included. The proportion of incomplete vaccination was 27.6% in Indigenous children and 21.6% in Mestizo children. Among Indigenous children, secondary and higher maternal education were associated with a 5 and 4 percentage point reduction in incomplete vaccination [-0.05 (95% CI: -0.08,-0.02) and -0.04 (95% CI: -0.07,-0.01), respectively]; while among Mestizo children, the reductions were 8 and 11 percentage points [-0.08 (95% CI: -0.11,-0.06) and -0.11 (95% CI: -0.13,-0.08)], compared to mothers who completed less than secondary education. Poisson models were consistent with the linear model. The mediation analysis showed large negative interaction, representing the reduced benefit of higher educational attainment for Indigenous women.
Conclusion: Smaller beneficial effects of maternal education level on children's vaccination status for Indigenous relative to Mestizos. Increasing education levels for all groups would inadvertently amplify existing ethnic gaps.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.socscimed.2025.117862 | DOI Listing |
Int J STD AIDS
March 2025
MAP Centre for Urban Health Solutions, St. Michael's Hospital, Toronto, ON, Canada.
BackgroundHepatitis B virus (HBV) disproportionately affects people at risk of HIV. Encounters for HIV post-exposure prophylaxis (PEP) create opportunities for HBV screening and prevention. We quantified HBV prevalence, susceptibility, and active/passive immunization use among patients seeking HIV PEP.
View Article and Find Full Text PDFEur J Immunol
March 2025
Sanquin Research and Landsteiner Laboratory, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.
Immunosenescence, age-related immune dysregulation, reduces immunity upon vaccinations and infections. Cytomegalovirus (CMV) infection results in declining naïve (T) and increasing terminally differentiated (T) T cell populations, further aggravating immune aging. Both immunosenescence and CMV have been speculated to hamper the formation of protective T-cell immunity against novel or emerging pathogens.
View Article and Find Full Text PDFThe therapeutic armamentarium that has been made available from the beginning of the emergency phase of the COVID-19 pandemic to date is briefly reviewed, and an overview of the real-world clinical evidence published by the Italian medical and scientific community during the last three years is presented herein. Prior to the introduction of a vaccine for SARS-CoV-2, several treatment options were implemented from the onset given the evidence that a "cytokine storm" was present during infection with SARS-CoV-2. However, with the exception of tocilizumab, baricitinib and perhaps anakinra, most studies with anti-cytokine biological agents in patients with severe COVID-19 did not show any significant clinical improvement or decrease in mortality at day 28.
View Article and Find Full Text PDFInt J MS Care
January 2025
From the Department of Neurology, Alexandria University, Alexandria, Egypt.
Background: Until the World Health Organization declared an end to COVID-19 as a global health emergency worldwide in 2023, people with multiple sclerosis (MS) were hesitant to get the COVID-19 vaccine. This study aimed to assess the final vaccination status, attitude, and adverse events related to the COVID-19 vaccine among people with MS in Egypt.
Methods: A self-administered survey was offered to people with MS who came to the Alexandria University MS Clinic in Egypt between June 2023 and November 2023.
EClinicalMedicine
March 2025
VA Boston Cooperative Studies Program, Boston, MA, USA.
Background: Novel strategies that account for population-level changes in dominant variants, immunity, testing practices and changes in individual risk profiles are needed to identify patients who remain at high risk of severe COVID-19. The aim of this study was to develop and prospectively validate a tool to predict absolute risk of severe COVID-19 incorporating dynamic parameters at the patient and population levels that could be used to inform clinical care.
Methods: A retrospective cohort of vaccinated US Veterans with SARS-CoV-2 from July 1, 2021, through August 25, 2023 was created.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!